CREABILIS
Creabilis is an emerging European specialty pharmaceutical company focused on dermatology. Creabilis discovers, develops and commercialises new medicines for a range of skin disorders, - an area of significant unmet medical need and high commercial potential. Creabilis has an exceptional track record in dermatological research and has used this experience to generate a rich pipeline of clinical and pre-clinical drug candidates that the company will market directly or in partnership. The most advanced product is CT327 for the treatment of psoriasis. CT327 will enter Phase II clinical trials in 2009. Creabilis' pipeline also includes a number of pre-clinical drug candidates arising from its ground breaking drug discovery programmes.
CREABILIS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Samone, Emilia-Romagna, Italy
Country:
Italy
Website Url:
http://www.creabilis-sa.com
Total Employee:
1+
Status:
Closed
Contact:
352 26 420 522
Email Addresses:
[email protected]
Total Funding:
51.45 M USD
Technology used in webpage:
LetsEncrypt Nginx CPanel DNS.COM 51.la
Current Advisors List
Current Employees Featured
Founder
Investors List
Sofinnova Partners
Sofinnova Partners investment in Series B - Creabilis
Abbott Biotech Ventures
Abbott Biotech Ventures investment in Series B - Creabilis
Neomed Management
Neomed Management investment in Series A - Creabilis
Sofinnova Partners
Sofinnova Partners investment in Series A - Creabilis
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2007-04-30 | Nautilus Biotech | Creabilis investment in Venture Round - Nautilus Biotech | 11.3 M USD |
Official Site Inspections
http://www.creabilis-sa.com
- Host name: 172.67.204.4
- IP address: 172.67.204.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
